2021 session details
Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of US-based, pre-series A-funded, therapeutic Biotech companies.
Free to attend, pre-registration only, Chatham House Rule forum hosted on Zoom where all participants are active discussants.
Agenda (All times in EDT)
Introduction from LSX to the forum, introductions from all participants and sharing of pre event benchmarking survey results
13:10 Key Insight Case Study With Q&A: How to Prevent a Bad Day for Your Start-Up: IP Lessons Learned from Company Formation, Drug Development, Partnering & Due Diligence
Chad Shear, Principal, Fish & Richardson
13:30 Executive Led Discussion: Securing Your Series A: What Investors Need to See (And What They Don't)
Bibhash Mukhopadhyay, Experienced Independent Investor
13:40 Interactive discussion and Q&A
13:55 Key Insight Case Study With Q&A: Partnering to Address the Challenges of a Start Up
Sameena Sharif, President, RPI, Premier Research
Nancy Koch, JD, CEO, Ophirex
14:15 General Discussion (suggested topics to include but not limited to)
15:00 Close Biotech Start Up CEO Forum